u/anya_antonsen

Nearly sent on the wrong network. The token symbol was identical and the address format was the only clue.

Was there potency testing on the finished preparation, or only on the starting material?

if the maths gives you a fraction of a unit, change the concentration

The intake asked me three questions and none of them were about my history. That told me everything I needed to know about the model.

Small fix — that is the network fee, not a supplier charge. The distinction matters for the complaint you are making.

Correction: that address format is not the chain you named. Worth checking before anybody follows this.

Pasted rather than typed the address, then checked the first and last six characters. Habit now.

Agreed, and the bit people skip is that the ladder is a tolerance ladder. It is not a potency ranking.

ask the pharmacy what the cash price is, it varies

What did the intake actually ask you?

Asked for potency testing on the finished preparation. They had it. I had assumed they would not.

Disagree — a 503B being registered does not make its preparations equivalent to an approved product. Different regulatory category entirely.

if the maths gives you a fraction of a unit, change the concentration

Cosigning the beyond-use date question. What it is based on tells you whether anybody has done stability work.

That reads like a titration plan and this board cannot give you one. Somebody who actually knows your history has to.

the same token exists on several chains and they are not interchangeable

salt forms are the recurring argument and the answer is boring

a rejected claim is not the same as a denied authorization

Pushback on the syringe advice: a U-100 barrel reads units of volume. Calling them "doses" is how the confusion starts.

confirmations are the only status that means anything

503A is patient-specific, 503B is outsourcing facility, they are not the same thing

Shook the first vial because nobody told me not to. It was fine, but I have swirled every one since.

I would not read the price difference as a quality signal. Most of it is the consultation model, not the vial.

A token symbol identifies an asset, not a network. The same symbol commonly exists on several chains with incompatible address formats, and sending across that boundary is generally unrecoverable.

Provincial plan, employer plan, or paying cash?

Special authorization is a documented exception process with published criteria. Applications that answer those criteria explicitly, point by point, fare better than general clinical narratives.

Was there a memo or tag requirement on that chain?

Disagree — that is your province’s formulary position and it does not carry to another.

Same. I got this wrong once, caught it because the units looked absurd, and have written on every vial since.

Confirmation took forty minutes on a busy evening and I had already written half an angry message. Deleted it.

Criteria changed at plan renewal and the denial that had been immovable simply did not apply any more.

Spent three weeks on what turned out to be a quantity limit rather than a coverage question.

That figure is the 68-week trial mean, not a weekly rate. Dividing it by the weeks gives you a number that does not mean anything.

Yes. Cash prices vary and comparing them before assuming coverage is the only route is worth doing.

Confirmation took forty minutes on a busy evening and I had already written half an angry message. Deleted it.

Confirmations are the count of blocks built on top of the one containing your transaction. Until there are some, the transaction is not settled in any meaningful sense.

2.4 is a ceiling, not a target

Not quite. Bacteriostatic and sterile water are not interchangeable for a multi-draw vial, and the difference is the preservative.

Right, and confirmations are the status. "Sent" means nothing until the chain agrees.

What dose and how many weeks at it before this started?